Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medtronic launches cardiac device in Europe
The Xcelerant Hydro Delivery System features a uniquely integrated sheath that contributes to the system’s low profile characteristics, which are intended to enable excellent tracking and access through
The Xcelerant Hydro Delivery System features a uniquely integrated sheath that contributes to the system’s low profile characteristics, which are intended to enable excellent tracking and access through
ImmuCell granted Anadis an exclusive, worldwide license to the human and environmental applications of its milk antibody technology. Under this agreement, ImmuCell is not obligated to fund further
The trial compared the pharmacokinetic (PK) profile of L-Dopa (levodopa) produced by a single oral dose of a prototype, sustained-release tablet of XP21279 to that of a near-equivalent
Paclitaxel injection is a generic version of Bristol-Myers Squibb’s Taxol (paclitaxel) injection USP, 6mg/mL, packaged in 100mg/16.7mL and 300mg/50mL multiple-dose vials.
The trial is a randomized, double-blinded, dummy-controlled study designed to evaluate the efficacy and safety of ThermoDox in combination with radiofrequency ablation (RFA) compared to RFA-alone. This 40
This study, which achieved all of its planned objectives, primarily measured the ability of Unigene’s proprietary oral delivery technology to significantly reduce the levels of an established biochemical
Omnilux New-U has been clinically proven to reduce periorbital wrinkles and to treat the visible signs of aging, using a combination of alternate treatments of infrared and red
RAV18 is a humanized antibody targeting the ADAM9 protein on cells. ADAM9 is expressed on many solid tumors and is thought to contribute to disease progression and metastasis.
At week 48 the proportion of patients with HIV levels below detectable was over 90%. Patients who were initially treated with 3TC but who changed to apricitabine (ATC)
JR-013 is a recombinant human erythropoietin for the treatment of renal anemia in dialysis patients and Growject is currently approved and marketed in Japan to treat short stature